Organization
Fundació Institut Germans Trias i Pujol
4 clinical trials
Clinical trial
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral TreatmentStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Phase 2b Randomized Double-blind, Placebo-controlled Trial to Estimate the Potential Efficacy and Safety of Two Repurposed Drugs, Acetylsalicylic Acid and Ibuprofen, for Use as Adjunct Therapy Added to, and Compared With, the Standard WHO-recommended TB Regimen (SMA-TB)Status: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF PilotStatus: Completed, Estimated PCD: 2021-06-30